Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Apr 2, 2026 8-K
SCHEDULE 13D Mar 31, 2026
10-K Mar 27, 2026 10-K
8-K Mar 27, 2026 8-K
8-K Mar 11, 2026 8-K
SCHEDULE 13D Mar 9, 2026
424B5 Mar 9, 2026 424B5
424B5 Mar 6, 2026 424B5
S-3MEF Mar 5, 2026 S-3MEF
SCHEDULE 13G/A Feb 10, 2026
8-K Feb 10, 2026 8-K
SCHEDULE 13G Feb 4, 2026
8-K Jan 29, 2026 8-K
4 Dec 16, 2025 4
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
8-K Nov 10, 2025 8-K
8-K Oct 31, 2025 8-K
8-K Oct 24, 2025 8-K
8-K Sep 19, 2025 8-K
4 Sep 5, 2025
4 Sep 5, 2025
4 Sep 5, 2025
8-K Aug 29, 2025 8-K
SCHEDULE 13G Aug 27, 2025
← Newer Page 2 of 17 · 403 filings Older →